Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?

AIDS. 2016 Jan;30(2):323-5. doi: 10.1097/QAD.0000000000000891.

Authors

Stefano Fagiuoli¹, Massimo Puoti, Giuliano Rizzardini

Affiliation

¹ aDepartment of Gastroenterology, Hepatology and Liver Transplantation, Papa Giovanni XXIII Hospital, Bergamo bDepartment of Infectious Diseases, Niguarda Cà Granda Hospital cDepartment of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy dSchool of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.

PMID: 26684824
DOI: 10.1097/QAD.0000000000000891

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / therapeutic use
HIV Infections / drug therapy
Hepacivirus*
Hepatitis C / drug therapy
Humans
Liver Transplantation*
Shoulder

Substances

Antiviral Agents